5472 x 3648 px | 46,3 x 30,9 cm | 18,2 x 12,2 inches | 300dpi
Aufnahmedatum:
27. Oktober 2026
Ort:
United Kingdom
Weitere Informationen:
. A domestic pile of shop-bought pain relief medicine includes boxes of paracetamol and ibuprofen from several UK supermarket and pharmacy own-label ranges. Identifiable packs from Sainsbury’s, Tesco, Asda and the Co-operative are stacked together, showing both brands of active ingredient and different pack sizes. The image concentrates on over-the-counter tablets kept at home, with product labels and strengths visible on the packaging. Paracetamol and ibuprofen are widely used for the short-term relief of pain, but they are different medicines with different dosing instructions, precautions and suitability for particular patients. Paracetamol is used for pain and fever; ibuprofen is a non-steroidal anti-inflammatory drug. Duplicate products containing the same active ingredient can raise the risk of accidental excess dosing, and ibuprofen is unsuitable for some people or conditions. Safe home storage, clear labelling and reading patient information are important issues when several packs accumulate. Over-the-counter medicines are sold in pharmacies and many supermarkets in the UK, usually in small packs with information about the active substance and dose. Paracetamol is a common treatment for pain and high temperature, while ibuprofen has anti-inflammatory properties as well as relieving pain. Packaging may carry a retailer's own label even though the active ingredient is also available under other brands. Consumers must read the dosing directions and consider warnings for age, pregnancy, other medication and medical conditions. Taking more than the recommended dose of paracetamol can cause severe liver damage. Medicines should be kept in original packs with their instructions and stored safely away from children. Having several brands in a cupboard can create confusion if people overlook duplicated active ingredients. The image fits discussion of medicine safety, household healthcare expenditure, pharmacy access and the regulation of retail packs.
